GEN: The Rebel Accelerates Process Development Cycles and Maximizes Bioreactor Utilization
BioPharma Reporter: 908 Devices launches a Rebel-lion in media analyzing
908 Devices launches the Rebel, the first at-line spent cell media analyzer for bioprocess labs
908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
908 Devices Addresses Emerging Novichok Nerve Agent Threat, Expands Capabilities for MX908 Chemical Detection Device
908 Devices broadens the ZipChip platform, brings new capability to biotherapeutics researchers
Miniaturization: A ‘Renaissance’ for Mass Spectrometers
908 Devices Secures $17.5 Million in Growth Funding
MX908 Used to Identify Substance That Hospitalized Police Officers in MA
908 Devices’ High-Pressure Mass Spectrometry (HPMS) Technology to Power Next-Generation Advanced Chemical Threat Detector for U.S. Department of Defense
Massachusetts Governor Charlie Baker tours new 908 Devices Boston Headquarters
908 Devices’ MX908 out-designs designer drugs, unlocks detection capabilities for more than 2000 fentanyl variants
908 Devices and Hangzhou Just Biotherapeutics Announce Joint Innovation Partnership
Subscribe to our newsletter!
Click Here to join our monthly newsletter.